311 related articles for article (PubMed ID: 20878980)
41. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.
Sanmartín E; Sirera R; Usó M; Blasco A; Gallach S; Figueroa S; Martínez N; Hernando C; Honguero A; Martorell M; Guijarro R; Rosell R; Jantus-Lewintre E; Camps C
Ann Surg Oncol; 2014 Feb; 21(2):612-20. PubMed ID: 24145997
[TBL] [Abstract][Full Text] [Related]
42. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
43. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
[TBL] [Abstract][Full Text] [Related]
44. A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer.
Xu W; Jia G; Davie JR; Murphy L; Kratzke R; Banerji S
J Thorac Oncol; 2016 Dec; 11(12):2150-2160. PubMed ID: 27498386
[TBL] [Abstract][Full Text] [Related]
45. Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer.
Metodieva SN; Nikolova DN; Cherneva RV; Dimova II; Petrov DB; Toncheva DI
Tumori; 2011; 97(1):86-94. PubMed ID: 21528670
[TBL] [Abstract][Full Text] [Related]
46. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.
Bhattacharjee A; Richards WG; Staunton J; Li C; Monti S; Vasa P; Ladd C; Beheshti J; Bueno R; Gillette M; Loda M; Weber G; Mark EJ; Lander ES; Wong W; Johnson BE; Golub TR; Sugarbaker DJ; Meyerson M
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13790-5. PubMed ID: 11707567
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
[TBL] [Abstract][Full Text] [Related]
48. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
[TBL] [Abstract][Full Text] [Related]
49. Impact of viral presence in tumor on gene expression in non-small cell lung cancer.
Kim Y; Pierce CM; Robinson LA
BMC Cancer; 2018 Aug; 18(1):843. PubMed ID: 30134863
[TBL] [Abstract][Full Text] [Related]
50. Transcriptomic Microenvironment of Lung Adenocarcinoma.
Bossé Y; Sazonova O; Gaudreault N; Bastien N; Conti M; Pagé S; Trahan S; Couture C; Joubert P
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):389-396. PubMed ID: 27956437
[No Abstract] [Full Text] [Related]
51. Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung?
Sun Z; Yang P; Aubry MC; Kosari F; Endo C; Molina J; Vasmatzis G
Mol Cancer; 2004 Dec; 3(1):35. PubMed ID: 15579197
[TBL] [Abstract][Full Text] [Related]
52. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.
Kikuchi T; Hassanein M; Amann JM; Liu Q; Slebos RJ; Rahman SM; Kaufman JM; Zhang X; Hoeksema MD; Harris BK; Li M; Shyr Y; Gonzalez AL; Zimmerman LJ; Liebler DC; Massion PP; Carbone DP
Mol Cell Proteomics; 2012 Oct; 11(10):916-32. PubMed ID: 22761400
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.
Rohrbeck A; Neukirchen J; Rosskopf M; Pardillos GG; Geddert H; Schwalen A; Gabbert HE; von Haeseler A; Pitschke G; Schott M; Kronenwett R; Haas R; Rohr UP
J Transl Med; 2008 Nov; 6():69. PubMed ID: 18992152
[TBL] [Abstract][Full Text] [Related]
54. Impact of collection and storage of lung tumor tissue on whole genome expression profiling.
Freidin MB; Bhudia N; Lim E; Nicholson AG; Cookson WO; Moffatt MF
J Mol Diagn; 2012; 14(2):140-8. PubMed ID: 22240448
[TBL] [Abstract][Full Text] [Related]
55. Reply to "MiR-205 and miR-375 microRNA Assays to Distinguish Squamous Cell Carcinoma From Adenocarcinoma in Lung Cancer Biopsies".
Patnaik SK; Yendamuri S; Mallick R; Dhillon SS
J Thorac Oncol; 2015 Jun; 10(6):e53. PubMed ID: 26001155
[No Abstract] [Full Text] [Related]
56. Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
Qi L; Chen L; Li Y; Qin Y; Pan R; Zhao W; Gu Y; Wang H; Wang R; Chen X; Guo Z
Brief Bioinform; 2016 Mar; 17(2):233-42. PubMed ID: 26254430
[TBL] [Abstract][Full Text] [Related]
57. Independent validation test of the vote-counting strategy used to rank biomarkers from published studies.
Rikke BA; Wynes MW; Rozeboom LM; Barón AE; Hirsch FR
Biomark Med; 2015; 9(8):751-61. PubMed ID: 26223535
[TBL] [Abstract][Full Text] [Related]
58. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.
Jiang F; Yin Z; Caraway NP; Li R; Katz RL
Neoplasia; 2004; 6(5):623-35. PubMed ID: 15548372
[TBL] [Abstract][Full Text] [Related]
59. Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.
Grunwald C; Koslowski M; Arsiray T; Dhaene K; Praet M; Victor A; Morresi-Hauf A; Lindner M; Passlick B; Lehr HA; Schäfer SC; Seitz G; Huber C; Sahin U; Türeci O
Int J Cancer; 2006 May; 118(10):2522-8. PubMed ID: 16353146
[TBL] [Abstract][Full Text] [Related]
60. An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
Girard L; Rodriguez-Canales J; Behrens C; Thompson DM; Botros IW; Tang H; Xie Y; Rekhtman N; Travis WD; Wistuba II; Minna JD; Gazdar AF
Clin Cancer Res; 2016 Oct; 22(19):4880-4889. PubMed ID: 27354471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
